Price
$69.58
Increased by +0.27%
Dollar Volume
216.37 M
ADR%
2.04
Earnings Report Date (estimate)
Feb 1, 23 (1.21)
Market Cap.
43.26 B
Shares Float
617.38 M
Shares Outstanding
621.79 M
Beta
0.93
Price / Earnings
8.90
BPR
202.19
20D Range
68.36 73.75
50D Range
68.29 74.02
200D Range
51.43 74.02
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Feb 2, 23 1.40
Decreased by -9.68%
1.21
Increased by +15.70%
Feb 1, 23 1.40
Decreased by -5.41%
1.21
Increased by +15.70%
Nov 1, 22 1.15
Decreased by -10.16%
1.21
Decreased by -4.96%
Oct 31, 22 1.15
Decreased by -24.84%
1.22
Decreased by -5.74%
Aug 1, 22 1.55
Decreased by -2.52%
1.28
Increased by +21.09%
Apr 27, 22 1.48
Decreased by -3.27%
1.37
Increased by +8.03%
Feb 2, 22 1.28
Increased by +19.63%
1.27
Increased by +0.79%
Oct 27, 21 1.53
Increased by +10.07%
1.32
Increased by +15.91%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 4.83 B
Decreased by -7.03%
1.60 B
Increased by +79.73%
Increased by +33.06%
Increased by +93.32%
Jun 30, 22 5.35 B
Decreased by -3.13%
1.39 B
Increased by +25.61%
Increased by +25.94%
Increased by +29.67%
Mar 31, 22 5.18 B
Decreased by -11.07%
1.03 B
Decreased by -20.19%
Increased by +19.92%
Decreased by -10.25%
Dec 31, 21 5.38 B
Decreased by -10.26%
1.04 B
Increased by +9.14%
Increased by +19.29%
Increased by +21.62%
Sep 30, 21 5.19 B
Decreased by -7.73%
888.00 M
Decreased by -63.84%
Increased by +17.10%
Decreased by -60.81%
Jun 30, 21 5.52 B
Increased by +2.96%
1.10 B
Increased by +37.27%
Increased by +20.01%
Increased by +33.32%
Mar 31, 21 5.83 B
Increased by +13.73%
1.29 B
Increased by +128.45%
Increased by +22.20%
Increased by +100.87%
Dec 31, 20 6.00 B
Increased by +7.76%
952.00 M
Increased by +21.90%
Increased by +15.86%
Increased by +13.12%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.